About Us
| Seven Spires Investments Limited is a technology sector investment vehicle established in 2003 with an annual budget of around £5m of investment funds. We invest in technology-based, private companies based in the United Kingdom. We like to see strong intellectual property in our investee companies. Particularly in the case of early-stage companies, this will often be in the form of patents, but not necessarily so. In any case we like to work with world-class scientists. With later-stage companies, proven revenue streams can to some extent offset our requirement for strong IP. We are looking for companies that can address global markets and which are expected to scale to a valuation in excess of $100m.
The fund will invest up to £5 million per year. We have no formal minimum level of investment. We are prepared to invest at every stage of a company’s development up to and including the last round of investment before IPO or trade sale. We usually co-invest with others and sometimes act as lead investor. We are interested in most high technology sectors with the exception of pharmaceutical drug development opportunities. Ian Page and Edward McCabe are the UK based management of the company. They report to the Board of Seven Spires Investments Limited. Ian Page, in addition to his Seven Spires role, is also a Visiting Professor at the Cass Business School in London and founder of AIM-listed, Oxford University spinout Celoxica Ltd. Previously he was Reader in Computation in the renowned Programming Research Group within Oxford University Computing Laboratory. Edward McCabe brings a wealth of experience from banking, investment management, and running a large corporate organisation as CEO and Chairman, in addition to co-founding several technology start-up companies. |
 |